InvestorsHub Logo
Followers 16
Posts 1135
Boards Moderated 0
Alias Born 11/21/2017

Re: BlueJordan post# 257131

Friday, 12/27/2019 9:34:51 AM

Friday, December 27, 2019 9:34:51 AM

Post# of 731856
I agree BlueJordan. I’ve had similar conversations with Dave. We ALL are lamenting the time that it has taken to get to topline data on this trial, but they’ve told us that in many ways they are doing pioneering work on this trial. As a clinician, I see the biggest issue as being how to adjust PFS eventing for psuedoprogression in this trial and get four different regulators to agree to their method(s). Building consensus is REALLY time consuming. I bet they’ve learned that all too well. Getting 66 neurosurgeons and PhDs to sign onto an interim paper in May 2018 also took more time than they anticipated.

I can wait a few more months on my investment for the binary event that is approaching. They seem to be preparing for success and commercialization. Based on what I’ve seen, that’s probably a smart bet. Demand for their personalized vaccine will be sky high with good data and approval.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News